ACRS: Aclaris Therapeutics Inc

ACRS News

• Zacks 14:00 Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy?
• Investing 21:28 Aclaris Therapeutics stock soars after positive Phase 2a trial results
• Investing 20:09 Aclaris reports positive results from ATI-2138 atopic dermatitis trial
• Investing 17:01 Aclaris Therapeutics at HCW Conference: Strategic Moves and Future Plans
• Investing 13:37 Aclaris Therapeutics joins Russell 3000 and Russell 2000 indexes
• Investing 20:48 Aclaris Therapeutics to Participate in the H.C. Wainwright  Inflammation & Immunology Virtual Conference
• Investing 11:29 Aclaris Therapeutics initiates Phase 1 trial for ATI-052 antibody
• Investing 11:20 Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
• Investing 11:04 InvestingPro’s Fair Value model captures 67% upside in Aclaris Therapeutics
• Investing 11:32 H.C. Wainwright maintains Buy on Aclaris stock, $16 target
• Investing 18:02 Aclaris Therapeutics at Jefferies Conference: Strategic Pipeline Advances
• Investing 11:05 Aclaris begins phase 2 trial for atopic dermatitis drug
• Investing 13:32 Aclaris Therapeutics to Participate in Two June Healthcare Conferences
• Investing 12:22 Wedbush sets Aclaris stock Outperform with $8 target
• Benzinga 11:43 This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Aclaris Therapeutics (NASDAQ:ACRS), Alkermes (NASDAQ:ALKS)
• Investing 19:09 Insurance broker Acrisure valued at $32 billion in funding round led by Bain Capital
• Investing 12:44 H.C. Wainwright cuts Aclaris stock price target to $16
• Seeking Alpha 12:09 Aclaris: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule